Oslo, 12 April 2021: In connection with the Annual General Meeting of Ultimovacs
ASA to be held on 15 April 2021, Jónas Einarsson, Chair of the Board of
Directors, has so far received proxy based voting rights without voting
instructions for 8,278,716 shares, representing 25.87% of the total voting
rights in the company.
With the addition of the 1,498,913 shares controlled by Radforsk, Jónas
Einarsson thus represents a total of 9,777,629 shares. This corresponds to
30.55% of the company's total number of shares and votes in connection with the
company's ordinary Annual General Meeting.
The proxies are only valid for the Annual General Meeting on 15 April 2021.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
For further information, please see www.ultimovacs.com or contact:
Jónas Einarsson, Chair of the Board of Directors of Ultimovacs ASA
Phone: +47 480 96 355
Carlos de Sousa, CEO
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Phone: +47 482 48632